Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsGlenmarkpharma

    Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More

    Jump to

    • Lupin, Sun Pharma, Dr Reddy's top picks: Arvind Bothra

      Arvind Bothra, vice president of institutional research at Religare Capital Markets says Lupin, Sun Pharmaceutical Industries and Dr Reddy's are top picks in the pharma space.

    • Keep Aurobindo Pharma, Glenmark Pharma in portfolio: Bodke

      Ajay Bodke, Hd-Investment Strategy at Prabhudas Lilladher advises to keep Aurobindo Pharma and Glenmark Pharma in the portfolio.

    • Prefer Dr Reddy's Labs, Aurobindo Pharma: Ajay Bodke

      Ajay Bodke, Head - Investment Strategy & Advisory at Prabhudas Lilladher advises to prefer Dr Reddys Laboratories, Glenmark Pharma and Aurobindo Pharma from the pharma space.

    • Bet on Glenmark Pharma, may test Rs 750: Aashish Tater

      Aashish Tater of FortuneWizard.com feels Glenmark Pharma is a safer bet. The stock may test Rs 750 in a year, he adds.

    • Buy Dish TV, Jubilant Food, Glenmark Pharma, NIIT: Chopra

      Manav Chopra of Nirmal Bang recommends buying Dish TV India with a target of Rs 63 and Jubilant Foodworks with a target of Rs 1390.

    • Bull's Eye: Buy Dish TV, YES Bank, Aurobindo, Glenmark

      Manav Chopra of Nirmal Bang advises buying Dish TV for a target price of 63 and Jubilant Foodworks for a target price of Rs 1,390.

    • Sell Glenmark Pharma, says Sudarshan Sukhani

      Sudarshan Sukhani of s2analytics.com is of the view that one may sell Glenmark Pharma as the stock may test lower levels.

    • Buy Glenmark Pharma, SKS Micro, Aban Offshore: D Cunha

      According to Lancelot D Cunha of ITI Wealth Management, one may buy Aban Offshore with a target of Rs 250.50 and Karnataka Bank with a target of Rs 102.50.

    • Bull's Eye: Buy Arvind, Idea, SKS Micro, Glenmark

      Lancelot D Cunha of ITI Wealth Management advises buying Glenmark Pharma for a target price of Rs 504.90 and SKS Microfinance for a target price of Rs 150.

    • Buy Finolex Ind, ILandFS Trans; sell Glenmark: Subramanium

      According to Krish Subramanium of Asit C. Mehta, one may sell Glenmark Pharma with a target of Rs 507 and The Ramco Cements with a target of Rs 187.

    • Bull's Eye: Buy Sun TV, Fortis, Finolex Ind; sell Glenmark

      Manav Chopra of Nirmal Bang advises buying Sun TV Network for a target price of Rs 470 and Future Retail for a target price of Rs 88.

    • Glenmark Pharma may touch Rs 658, says Sriram Rathi

      Sriram Rathi of Anand Rathi is positive on Glenmark Pharma with a target of Rs 658.

    • Buy Glenmark Pharma, NCC, Exide, Eveready Industries: Diwan

      Prakash Diwan of Altamount Capital recommends going long on Glenmark Pharma with a target of Rs 586 and NCC with a target of Rs 22.50.

    • Bull's Eye: Buy Glenmark, Karur Vysya; sell Indiabulls Real

      Vishal Malkan of malkansview.com advises selling Rural Electrification Corporation October future with a target price of Rs 184 and Indiabulls Real Estate October future with a target price of Rs 60.

    • Exit Glenmark Pharma above Rs 580: SP Tulsian

      SP Tulsian of sptulsian.com suggests exiting Glenmark Pharma above Rs 580 and look to enter when it corrects to level of about Rs 530.

    • Here's how to play L&T, Infosys, DLF, Glenmark today

      MS is overweight on Infosys with a target price of Rs 3,695. The company is likely to generate higher revenue in FY14 as compared to FY13. The margins of the company are a function of the management execution and not necessarily its macros.

    • Do not buy Tata Steel, prefer Idea Cellular: SP Tulsian

      According SP Tulsian of sptulsian.com, one should not buy Tata Steel. "One may prefer Idea Cellular, which has corrected today," he adds.

    • Buy Glenmark Pharma; target Rs 650: Rahul Mohindar

      Rahul Mohindar of viratechindia.com recommends buying Glenmark Pharma at current levels or at around Rs 600 with a target of Rs 650 and stoploss at Rs 580-585.

    • Buy Glenmark Pharma, GAIL: Sudarshan Sukhani

      Sudarshan Sukhani of s2analytics.com is of the opinion that one may buy Glenmark Pharma as the stock has been rallying and is in a bull market of its own.

    • Positive on Glenmark, GAIL, short IndusInd Bank: Sukhani

      Bank Nifty will continue to fall for some time now. Sudarshan Sukhani suggests shorting IndusInd Bank next week. He is positive on the pharma sector and has a ‘Buy‘ on Glenmark Pharma and GAIL.

    • Go long on Dabur, Idea, Glenmark Pharma, Tata Global: Kapur

      According to Ashish Kapur of Investshoppe, one may go long on Dabur India with a target of Rs 165 and a stop loss at Rs 157 and advises to go long on Idea Cellular with a target of Rs 164 and stop loss at Rs 155.

    • Bull's Eye: Buy Idea, Jet Airways; sell Sun TV, Aurobindo

      Aashish Tater of FortuneWizard.com advised going short on Reliance Communications with a target price of Rs 130 and Sun TV Network with a target price of Rs 375.

    • Go long on Tech Mahindra, Glenmark Pharma; sell HDIL: Kapur

      According to Ashish Kapur of Investshoppe one may go long on Tech Mahindra with a target of Rs 1170 and a stop loss at Rs 1100 and advises to sell Housing Development and Infrastructure (HDIL) with a target of Rs 37 and a stop loss at Rs 40.

    • Bull's Eye: Buy SpiceJet, Tech Mahindra, Glenmark, IGL

      Aashish Tater of FortuneWizard.com advised buying Hexaware Technologies with a target price of Rs 99.50 and SpiceJet with a target price of Rs 29.

    • Buy Pidilite, Glenmark, Indiabulls Real, Voltas: Mirani

      According to Nooresh Mirani of AMSEC Research one can buy Pidilite Industries with a target price of Rs 350 and advises to also buy Glenmark Pharma with an intraday target price of Rs 650.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347